IGC Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGC Pharma and other ETFs, options, and stocks.About IGC
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development.
IGC Key Statistics
Stock Snapshot
With a market cap of 27.97M, IGC Pharma(IGC) trades at $0.29. The stock has a price-to-earnings ratio of -3.73.
During the trading session on 2026-01-27, IGC Pharma(IGC) shares reached a daily high of $0.30 and a low of $0.29. At a current price of $0.29, the stock is +0.5% higher than the low and still -0.9% under the high.
Trading volume for IGC Pharma(IGC) stock has reached 129.7K, versus its average volume of 474.32K.
The stock's 52-week range extends from a low of $0.25 to a high of $0.50.
The stock's 52-week range extends from a low of $0.25 to a high of $0.50.
IGC News
IGC Pharma (IGC) announced the addition of Integrative Clinical Trials, located in Brooklyn, New York, as a new clinical site participating in the Company’s Pha...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.